Erste Asset Management GmbH Has $2.68 Million Stake in HCA Healthcare, Inc. $HCA

Key Points

• Erste Asset Management GmbH reduced its stake in HCA Healthcare, Inc. by 18.5%, now holding 7,829 shares worth approximately $2.68 million.
• HCA Healthcare reported a better-than-expected quarterly EPS of $6.84, exceeding the consensus estimate of $6.20, and experienced a 6.4% year-over-year revenue increase.
• The company announced a quarterly dividend of $0.72 to be paid on September 30th, giving it a 0.7% yield.

Erste Asset Management GmbH cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 7,829 shares of the company's stock after selling 1,772 shares during the period. Erste Asset Management GmbH's holdings in HCA Healthcare were worth $2,679,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of HCA. Avantax Advisory Services Inc. grew its stake in shares of HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after buying an additional 32 shares during the period. Horizon Investments LLC raised its stake in shares of HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after purchasing an additional 33 shares in the last quarter. Catalyst Financial Partners LLC raised its stake in HCA Healthcare by 4.3% during the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after acquiring an additional 36 shares during the period. RWA Wealth Partners LLC grew its position in HCA Healthcare by 2.0% in the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock worth $658,000 after purchasing an additional 37 shares during the last quarter. Finally, Moors & Cabot Inc. grew its position in HCA Healthcare by 4.8% in the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after purchasing an additional 39 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.2%

HCA stock traded up $0.61 during midday trading on Friday, reaching $404.87. The company had a trading volume of 1,081,188 shares, compared to its average volume of 1,326,629. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $94.74 billion, a P/E ratio of 17.02, a PEG ratio of 1.27 and a beta of 1.39. The company has a 50 day moving average of $373.91 and a two-hundred day moving average of $354.02.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

Several research analysts have recently issued reports on HCA shares. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Finally, Barclays reduced their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.